Correlation Between Assembly Biosciences and ARCA Biopharma
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and ARCA Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and ARCA Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and ARCA Biopharma, you can compare the effects of market volatilities on Assembly Biosciences and ARCA Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of ARCA Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and ARCA Biopharma.
Diversification Opportunities for Assembly Biosciences and ARCA Biopharma
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Assembly and ARCA is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and ARCA Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARCA Biopharma and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with ARCA Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARCA Biopharma has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and ARCA Biopharma go up and down completely randomly.
Pair Corralation between Assembly Biosciences and ARCA Biopharma
Given the investment horizon of 90 days Assembly Biosciences is expected to generate 0.54 times more return on investment than ARCA Biopharma. However, Assembly Biosciences is 1.85 times less risky than ARCA Biopharma. It trades about 0.04 of its potential returns per unit of risk. ARCA Biopharma is currently generating about -0.02 per unit of risk. If you would invest 1,296 in Assembly Biosciences on September 1, 2024 and sell it today you would earn a total of 408.00 from holding Assembly Biosciences or generate 31.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 83.33% |
| Values | Daily Returns |
Assembly Biosciences vs. ARCA Biopharma
Performance |
| Timeline |
| Assembly Biosciences |
| ARCA Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Assembly Biosciences and ARCA Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assembly Biosciences and ARCA Biopharma
The main advantage of trading using opposite Assembly Biosciences and ARCA Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, ARCA Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will offset losses from the drop in ARCA Biopharma's long position.| Assembly Biosciences vs. Spero Therapeutics | Assembly Biosciences vs. Achilles Therapeutics PLC | Assembly Biosciences vs. Instil Bio | Assembly Biosciences vs. CytomX Therapeutics |
| ARCA Biopharma vs. Aerovate Therapeutics | ARCA Biopharma vs. Adagene | ARCA Biopharma vs. Acrivon Therapeutics, Common | ARCA Biopharma vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |